Aripiprazole treatment for psychosis associated with Friedreich's ataxia [1]

General Hospital Psychiatry

Volumn 27, Issue 5, 2005, Pages 372-

  Chan, Yiu Chung ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; QUETIAPINE; RISPERIDONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; FATIGUE; FEMALE; FRIEDREICH ATAXIA; HUMAN; INSOMNIA; LETTER; MUSCLE STIFFNESS; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SEDATION; SIDE EFFECT; VISUAL IMPAIRMENT;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FRIEDREICH ATAXIA; HUMANS; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES;

EID: 24944496829     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2005.05.004     Document Type: Letter

References (5)

1. M. Victor, and A.H. Ropper Principles of neurology 7th ed. 2001 McGraw-Hill New York 1145 1147
2. W.A. Lishman Organic psychiatry, the psychological consequences of cerebral disorder 3rd ed. 1998 Blackwell Scientific Publications Oxford 705 706
3. M. Salbenblatt, R.D. Buzan, and S.L. Dubovsky Risperidone treatment for psychosis in end-stage Friedreich's ataxia Am J Psychiatry 157 2 2000 303
4. M. White, R. Lalonde, and T. Botez-Marquard Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia Acta Neurol Scand 102 2000 222 226
5. Z. Li, J. Ichikawa, J. Dai, and H.Y. Meltzer Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain Eur J Pharmacol 493 1-3 2004 75 83